Finance

Lists
Why is BFRI down 2.40%?
Dive Deeper
BFRI:NASDAQ
Biofrontera Inc
$1.02
-2.40%
(-0.025) 1D
Oct 2, 2:17:59 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BFRI...
Open
$1.11
High
$1.12
Low
$1.01
Mkt. cap
15.08M
Avg. vol.
677.56K
Volume
215.35K
52-wk high
$1.66
52-wk low
$0.55
EPS
-$0.59
Beta
0.86
Shares outstanding
14.85M
No. of employees
89
Open
$1.11
High
$1.12
Low
$1.01
Mkt. cap
15.08M
Avg. vol.
677.56K
Volume
215.35K
52-wk high
$1.66
52-wk low
$0.55
EPS
-$0.59
Beta
0.86
Shares outstanding
14.85M
No. of employees
89
News stories
From web sources and news partners
About Biofrontera Inc
CEO-
Employees89
Founded2015
HeadquartersWoburn, Massachusetts, United States
SectorPharmaceutical industry
Websitebiofrontera-us.com
Analyst
Recommendation
Action
Price target
Projected
Date
Bruce Jackson
Benchmark Co.
Buy
Maintained
$3.00
+195.6%
05/19/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
$9.00
+786.7%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.99M
17.10M
10.08M
12.00M
Cost of goods sold
2.04M
3.01M
2.12M
2.41M
Cost of revenue
2.04M
3.01M
2.12M
2.41M
Research and development expenses
854.00K
787.00K
900.00K
448.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.37M
8.74M
11.00M
9.67M
Operating expense
11.22M
9.53M
11.90M
10.12M
Total operating expenses
13.27M
12.54M
14.01M
12.53M
Operating income
-6.28M
4.56M
-3.93M
-524.00K
Other non operating income
-255.00K
503.00K
-699.00K
70.00K
EBT including unusual items
-6.64M
5.64M
-4.75M
-581.00K
EBT excluding unusual items
-6.64M
4.94M
-4.75M
-580.00K
Income tax expense
6.00K
-
-
23.00K
Effective tax rate
-0.09%
-
-
-3.96%
Other operating expenses
-
-
-
-
Net income
-6.65M
5.64M
-4.75M
-604.00K
Net profit margin
-95.15%
32.98%
-47.12%
-5.03%
Earnings per share
-0.57
0.50
-0.41
-0.05
Interest and investment income
-
-
-
-
Interest expense
-111.00K
-121.00K
-125.00K
-126.00K
Net interest expenses
-111.00K
-121.00K
-125.00K
-126.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.26M
4.62M
-3.87M
-459.00K
Gain or loss from assets sale
-
-700.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps